Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial.
about
Short-course versus prolonged-course antibiotic therapy for hospital-acquired pneumonia in critically ill adultsProcalcitonin to initiate or discontinue antibiotics in acute respiratory tract infectionsShort-course versus prolonged-course antibiotic therapy for hospital-acquired pneumonia in critically ill adultsAdvances in antibiotic therapy in the critically illProcalcitonin-guided antibiotic therapy for septic patients in the surgical intensive care unitUse of rapid diagnostic techniques in ICU patients with infectionsStrategies for appropriate antibiotic use in intensive care unitMeta-analysis and systematic review of procalcitonin-guided therapy in respiratory tract infectionsProcalcitonin-guided therapy in intensive care unit patients with severe sepsis and septic shock--a systematic review and meta-analysisAME evidence series 001-The Society for Translational Medicine: clinical practice guidelines for diagnosis and early identification of sepsis in the hospitalUrosepsis--Etiology, Diagnosis, and TreatmentNon-Intensive Care Unit Acquired Pneumonia: A New Clinical Entity?Antibiotic stewardship ward rounds and a dedicated prescription chart reduce antibiotic consumption and pharmacy costs without affecting inpatient mortality or re-admission ratesEffectiveness and safety of procalcitonin evaluation for reducing mortality in adults with sepsis, severe sepsis or septic shock.Advances in Intra-abdominal Sepsis: What Is New?Procalcitonin for diagnosis of bacterial pneumonia in critically ill patients during 2009 H1N1 influenza pandemic: a prospective cohort study, systematic review and individual patient data meta-analysis.Antibiotic stewardship in the intensive care unit.The diagnostic and prognostic accuracy of five markers of serious bacterial infection in Malawian children with signs of severe infectionDiagnostic and prognostic value of procalcitonin among febrile critically ill patients with prolonged ICU stayUsing Procalcitonin to Guide Antibiotic Therapy.Biomarker-guided antibiotic therapy-strengths and limitationsProcalcitonin biomarker kinetics fails to predict treatment response in perioperative abdominal infection with septic shockMonitoring treatment response in abdominal sepsis with procalcitonin--if only!Procalcitonin decrease over 72 hours in US critical care units predicts fatal outcome in sepsis patients.A focus on intra-abdominal infections.Neonatal Procalcitonin Intervention Study (NeoPInS): Effect of Procalcitonin-guided decision making on duration of antibiotic therapy in suspected neonatal early-onset sepsis: A multi-centre randomized superiority and non-inferiority Intervention StSerum procalcitonin as a diagnostic marker for neonatal sepsis: a systematic review and meta-analysis.Prevention, diagnosis, therapy and follow-up care of sepsis: 1st revision of S-2k guidelines of the German Sepsis Society (Deutsche Sepsis-Gesellschaft e.V. (DSG)) and the German Interdisciplinary Association of Intensive Care and Emergency MedicineDiagnostic accuracy of procalcitonin in critically ill immunocompromised patients.Procalcitonin to guide duration of antibiotic therapy in intensive care patients: a randomized prospective controlled trialProcalcitonin for diagnosis of infection and guide to antibiotic decisions: past, present and future.Prohormones for prediction of adverse medical outcome in community-acquired pneumonia and lower respiratory tract infections.Procalcitonin to guide duration of antimicrobial therapy in intensive care units: a systematic review.Procalcitonin to guide initiation and duration of antibiotic treatment in acute respiratory infections: an individual patient data meta-analysis.Procalcitonin guidance for reduction of antibiotic use in patients hospitalized with severe acute exacerbations of asthma: a randomized controlled study with 12-month follow-upNew approaches to sepsis: molecular diagnostics and biomarkers.Procalcitonin and procalcitonin kinetics for diagnosis and prognosis of intravascular catheter-related bloodstream infections in selected critically ill patients: a prospective observational study.Adoption of a High-Impact Innovation in a Homogeneous PopulationPrognostic and diagnostic value of eosinopenia, C-reactive protein, procalcitonin, and circulating cell-free DNA in critically ill patients admitted with suspicion of sepsisInterventions to improve antibiotic prescribing practices for hospital inpatients.
P2860
Q24187768-E8FA82AD-7BC6-4A79-BB61-CA7ED04885B1Q24200676-4CB5A8F1-42A9-42F9-82C7-524F226272EAQ24236108-9AC532DB-A414-40F2-B682-BA27A0A359B0Q26749328-41DF44DC-A97B-481F-8DF8-2B1B7F337237Q26798459-F13E1ED5-2B00-47A0-A665-9AF9FE5ED10BQ26866463-1BA1EB61-4636-459F-8C22-A6B4137821AEQ27002517-CBE6F2CF-D11C-41AD-BDF2-AC31A20F2031Q27023057-A52C21BE-6380-4A58-B1F8-AF182E5A262CQ27028085-7EF56A20-4A7E-4BD5-BB72-DA4D661982D1Q28077765-C6B3834D-74D7-41D8-B3D3-DC470BD73E72Q28078523-BE934CE8-40C7-4DEC-B472-242BED00B013Q28080078-94379AA6-B3BF-42AD-B6C6-9D27AE31F97FQ28536492-6BDFD603-4D63-4DDA-AE28-E97276CA9FD0Q30238953-9E03AD77-0B1F-4904-AD3D-ADDD05BD6944Q30279142-E1763BAF-AA59-47C0-AA77-08D62C59ACD2Q30360003-1788AB87-6D04-427D-9AB6-15303C0759C0Q30408712-28ECC3BE-0708-4A45-9674-38D645C0ACBAQ33493063-F15E821C-BDE3-4818-BD5E-2572C306E237Q33520362-FE95F955-304C-4570-B7D5-05394528C490Q33629591-DEB2D0EF-F3EC-4D86-8778-3D5ADCEE9CEAQ33747590-97F645F7-97E1-4C6B-BBEB-6A4599CE95F5Q33750023-0214EE4C-F472-4F41-A7D4-91094331FE19Q33752801-9B02B304-E216-42DB-AF85-8CF25B4BFB97Q33754533-849DF9C2-E728-4D90-86E2-CD9982C1F6ABQ33763449-C5507109-371F-4A3C-9BEA-5A9C6A48D40CQ33766905-5E0419D6-BB70-43C8-80C8-7280DC7AA19DQ33838503-975694FE-F5B9-4BF0-9704-16BF57091B32Q33974292-6245B5F4-D37B-4AD1-AE6C-A81895FD5191Q34001903-6A1DCF56-B093-4FD8-A4B0-322A4351432BQ34017829-909D24FE-14B2-4AA0-BB6A-2EBB8809BD43Q34026963-BAFF111B-201A-45D9-AC2D-FBF31DDB5E4DQ34026975-8802CBEA-4E28-413C-AE5F-7658373B506EQ34027944-79262F32-F471-4063-ABE3-388373F1D52CQ34264291-3C7C16B6-9F50-448E-AA14-26A64321E956Q34271299-A9F906C7-7023-4432-928B-912D16A38B26Q34303687-D816800B-AF26-41F3-B83F-54FDCA759127Q34436184-AD4024A8-47A2-47AE-819B-3F079A340A74Q34481134-1320485C-4B25-4EB2-8D7A-CC080FACDB31Q34500700-81D17C82-6E1E-40B1-ACC6-0272196AB408Q34550823-ABE73E96-A8C7-45D3-8525-793ED1038387
P2860
Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Use of procalcitonin to shorte ...... patients: a randomized trial.
@en
Use of procalcitonin to shorte ...... patients: a randomized trial.
@nl
type
label
Use of procalcitonin to shorte ...... patients: a randomized trial.
@en
Use of procalcitonin to shorte ...... patients: a randomized trial.
@nl
prefLabel
Use of procalcitonin to shorte ...... patients: a randomized trial.
@en
Use of procalcitonin to shorte ...... patients: a randomized trial.
@nl
P2093
P2860
P1476
Use of procalcitonin to shorte ...... patients: a randomized trial.
@en
P2093
Jean-Daniel Graf
Jérôme Pugin
Peter Rohner
P2860
P304
P356
10.1164/RCCM.200708-1238OC
P407
P577
2007-12-20T00:00:00Z